CAM
EBS icon

Congress Asset Management’s Emergent Biosolutions EBS Stock Holding History

Congress Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-63,813
Closed -$3.34M – 346
2019
Q3 		$3.34M Buy
63,813
+3,353
+6% +$156K 0.04% 227
2019
Q2 		$2.92M Sell
60,460
-12,698
-17% -$609K 0.04% 245
2019
Q1 		$3.7M Sell
73,158
-1,715
-2% -$101K 0.05% 217
2018
Q4 		$4.44M Sell
74,873
-8,248
-10% -$532K 0.07% 166
2018
Q3 		$5.47M Sell
83,121
-4,861
-6% -$284K 0.07% 178
2018
Q2 		$4.44M Buy
87,982
+3,251
+4% +$169K 0.06% 194
2018
Q1 		$4.46M Buy
84,731
+23,168
+38% +$1.15M 0.06% 188
2017
Q4 		$2.86M Buy
61,563
+3,507
+6% +$148K 0.04% 227
2017
Q3 		$2.35M Buy
58,056
+5,976
+11% +$216K 0.04% 236
2017
Q2 		$1.77M Buy
52,080
+4,632
+10% +$143K 0.03% 177
2017
Q1 		$1.38M Buy
47,448
+30,824
+185% +$938K 0.03% 185
2016
Q4 		$546K Buy
16,624
+9,819
+144% +$294K 0.01% 200
2016
Q3 		$215K Buy
+6,805
New +$198K ﹤0.01% 244

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Congress Asset Management's EBS Position: Q4 2019 in Review

Congress Asset Management sold out of Emergent Biosolutions (EBS) in Q4 2019, closing a stake of 63,813 shares — an estimated $3.34M sold.

Congress Asset Management first reported a position in EBS in Q3 2016 and held it in 13 quarters. The position peaked at $5.47M in Q3 2018. 236 funds tracked by Wall St. Rank hold EBS as of Q4 2019.

  • Congress Asset Management reported no remaining Emergent Biosolutions position as of Q4 2019 after selling out during the quarter.
  • Congress Asset Management sold 63,813 Emergent Biosolutions shares in Q4 2019, an estimated $3.34M.
  • Congress Asset Management first reported a position in Emergent Biosolutions in Q3 2016 and held it in 13 quarters.
  • Congress Asset Management's Emergent Biosolutions position peaked at $5.47M in Q3 2018.
  • 236 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2019.

Based on Congress Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.